Stephens & Co. Reiterates Overweight on ModivCare, Maintains $95 Price Target
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst Scott Fidel reiterates an Overweight rating on ModivCare (NASDAQ:MODV) and maintains a $95 price target.
June 06, 2023 | 11:43 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. analyst Scott Fidel reiterates an Overweight rating on ModivCare and maintains a $95 price target.
The reaffirmed Overweight rating and maintained $95 price target by Stephens & Co. analyst Scott Fidel indicates a positive outlook for ModivCare's stock in the short term. This news is highly relevant and important for investors in MODV, as it reflects the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100